drugset / Trial / NCT00220220

Amlodipine as add-on to Olmesartan in Hypertension

NCT00220220

Phase 3 Completed 429 enrolled Sankyo Pharma Gmbh
RandomizedParallel-groupDouble-blindTreatment

Summary

Test the efficacy and safety of the combination of olmesartan and amlodipine in hypertensive patients whose blood pressure is not adequately controlled with olmesartan alone.

Timeline

Start
2005-04
Primary completion
Completion
2007-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified 5 mg
Subject Amlodipine Other / unclassified 10 mg
Background Olmesartan medoxomil Unknown 20 mg